Argatroban formulation comprising an acid as solubilizer

Details for Australian Patent Application No. 2006285097 (hide)

Owner Baxter International Inc. Baxter Healthcare S.A.

Inventors Owoo, George; Burgos, Richard A.

Agent Peter Maxwell & Associates

Pub. Number AU-B-2006285097

PCT Pub. Number WO2007/027565

Priority 60/713,403 01.09.05 US

Filing date 28 August 2006

Wipo publication date 8 March 2007

Acceptance publication date 18 August 2011

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 31/47 (2006.01) - Quinolines

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/027565 Priority application(s): WO2007/027565

18 August 2011 Application Accepted

  Published as AU-B-2006285097

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006285106-Gaming machines having rhythmic reels

2006285092-Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents